GlassScriptPhysician profile
Lori Lynn Blackmer
NPI 1760451595
$4,361.06
in general payments reported to CMS, 2019-2025
19 companies · $678 in 2025
The $678 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.62 · 2020: $160 · 2021: $191 · 2022: $482 · 2023: $2,583 · 2024: $173 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,902 · Food and Beverage: $1,432 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,902.22 |
| Food and Beverage | $1,431.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,145.08 | 2023 | Clarus, Humphrey Field Analyzer (Hfa3), Forum |
| Oyster Point Pharma, INC. | $390.24 | 2022-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $384.84 | 2019-2025 | Tryptyr, Precision7, Total30 |
| Bausch & Lomb Americas INC. | $376.91 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Dompe US, INC. | $153.93 | 2024-2025 | Oxervate |
| Allergan, INC. | $147.94 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $115.29 | 2025 | Acthar |
| Coopervision INC. | $96.01 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.43 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $86.04 | 2021-2023 | Cequa |
| Abbvie INC. | $75.25 | 2022-2023 | Lumigan, Alphagan P, Vuity |
| Novartis Pharmaceuticals Corporation | $68.93 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $54.71 | 2025 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $51.57 | 2025 | |
| Aerie Pharmaceuticals, INC. | $36.92 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $33.14 | 2022-2023 | Tearlab Osmolarity System |
| Kala Pharmaceuticals, INC. | $21.76 | 2019 | |
| Eyevance Pharmaceuticals LLC | $15.76 | 2020 | |
| Glaukos Corporation | $14.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Blackmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.